Commentary: Chlamydia trachomatis screening: What are we trying to do?

International Journal of Epidemiology

Volumn 38, Issue 2, 2009, Pages 449-451

  Peterman, Thomas A ^a   Gottlieb, Sami I ^a   Berman, Stuart M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE DURATION; GEOGRAPHIC DISTRIBUTION; GONORRHEA; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; MASS SCREENING; NOTE; PELVIC INFLAMMATORY DISEASE; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; SEXUAL BEHAVIOR;

ADOLESCENT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MASS SCREENING; PELVIC INFLAMMATORY DISEASE; YOUNG ADULT;

CHLAMYDIA TRACHOMATIS;

EID: 64349116498     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyn345     Document Type: Note

References (14)

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2004. Atlanta, GA: US. Department of Health and Human Services, September 2005.
2. Herrmann B, Egger M. Genital Chlamydia trachomatis infections in Uppsala County, Sweden, 1985-1993: Declining rates for how much longer? Sex Transm Dis 1995;22:253-60.
3. Brunham RC, Pourbohloul B, Mak S, White R, Rekart ML. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005;192:1836-44.
4. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-66.
5. Low N, Bender N, Nartey L, Shang A, Stephenson J. Effectiveness of chlamydia screening: Systematic review. Int J Epidemiol 2009;38 435-448.
6. Velicko I, Kuhlmann-Berenzon S, Blaxhult A. Reasons for the sharp increase of genital chlamydia infections reported in the first months of 2007 in Sweden. Eurosurveillance 2007;12:311-15.
7. Fine D, Dicker L, Mosure D, Berman S, Region X. Infertility Prevention Project. Increasing Chlamydia positivity in women screened in family planning clinics: Do we know why? Sex Transm Dis 2008;35 47-52.
8. Sutton MY, Sternberg M, Zaidi A, St. Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005;32:778-84.
9. Ostergaard L, Andersen B, Moller JK, Olesen F. Home sampling vs conventional swab sampling for screening of Chlamydia trachomatis in women: A cluster-randomized 1-year follow-up study. Clin Infect Dis 2000;31:951-57.
10. Clark KL, Howell R, Li Y et al. Hospitalization rates in female US Army recruits associated with a screening program for Chlamydia trachomatis. Sex Transm Dis 2002;29:1-5.
11. Cohen DA, Nsuami M, Martin DH, Farley TA. Repeated school-based screening for sexually transmitted diseases: A feasible strategy for reaching adolescents. Pediatrics 1999;104:1281-85.
12. Hodgins S, Peeling RW, Dery S et al. The value of mass screening for chlamydia control in high prevalence communities. Sex Transm Infect 2002;78 (Suppl 1):i64-68.
13. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: Results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40.
14. Center for Disease Control. VD Statistical Letter, Issue 126. Atlanta, GA: US. Department of Health and Human Services, May 1977.